Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications
In: Business Wire (English), 2023-06-06
Online
Zeitungsartikel
Zugriff:
RxLightning, creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability, today announced that it closed a $17.5 million Series A investment to support the company’s growth and further remove barriers to life-saving therapies. The round was led by LRVHealth, with participation from McKesson Ventures and existing investors Novartis (dRx Capital), Onco360 (BrightSpring Health Services), Hearst Ventures, and HealthX Ventures. This investment brings RxLightning’s total capital raised since inception to $20.5 million. [ABSTRACT FROM PUBLISHER]
Titel: |
RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications
|
---|---|
Autor/in / Beteiligte Person: | RxLightning |
Zeitschrift: | Business Wire (English), 2023-06-06 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|